Thomas Pickel

Scientist II, Oligonucleotide Process Development at Biogen, USA

Speaker

Tom Pickel earned his Ph.D. in 2019 from Emory University, where his research focused on the coordination chemistry of early transition metals and the development of novel synthetic methods. He joined Biogen later that year as a postdoctoral scientist, working on the development of a platform for pretargeted imaging of oligonucleotides in the CNS. In 2021, he transitioned to Biogen’s Oligonucleotide Process Development group, where he supports the development and scale-up of preclinical and early-stage oligonucleotides prepared via solid-phase synthesis, along with efforts to advance liquid-phase synthesis strategies.